-
Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
Linschoten, M., Geels, J., van Werkhoven, E., Visser-Wisselaar, H., Chamuleau, M. E. D., Teske, A. J., Robbers, L., Oerlemans, S., Crommelin, H., Breems-de Ridder, M., Schut, A., Asselbergs, F. W. & on behalf of the HOVON 170 DLBCL – ANTICIPATE consortium, 1 Dec 2025, In: Cardio-Oncology. 11, 1, 8.Research output: Contribution to journal › Article › Academic › peer-review
-
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysis
Nab, L., Visser, C., van Bussel, B. C. T., Beishuizen, A., Bemelmans, R. H. H., ten Cate, H., Croles, F. N., van Guldener, C., de Jager, C. P. C., Huisman, M. V., Nijziel, M. R., Kamphuisen, P. W., Klok, F. A., Koster, S. C. E., Kuşadasi, N., Meijer, K., den Uil, C. A., Schutgens, R. E. G., Stam, F. & Vlaar, A. P. J. & 5 others, , Dec 2025, In: Scientific Reports. 15, 1, p. 10321 1 p., 10321.Research output: Contribution to journal › Article › Academic › peer-review
-
Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: a systematic review and meta-analysis
Geels, J., van Rhenen, A., Gradowska, P., Asselbergs, F. W. & Linschoten, M., 2025, (E-pub ahead of print) In: Leukemia.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
